Zane Starkewolfe is an Associate Director of New Venture Resources at UC Davis Venture Catalyst. He works to provide support and identify early-stage funding for UC Davis researchers engaged in translational research. He has more than 20 years of experience in science-based entrepreneurship in the biotechnology and pharmaceutical industries. Dr. Starkewolfe previously worked at Burrill & Company, a San Francisco-based venture capital and investment banking firm focused on the life sciences, with over $1.8 billion under management, where he evaluated investment opportunities, helped raise new venture funds and advised companies on financing, business development, intellectual property licensing, clinical trial design and M&A. Dr. Starkewolfe successfully closed the acquisitions of two oncology companies of total deal value of over $80M. While at Burrill, Dr. Starkewolfe helped launch a startup developing a diagnostic platform for the assessment of neurological disorders. He previously co-founded a point-of-care diagnostic company based on UC Davis technology in nanomaterials. Dr. Starkewolfe obtained his Ph.D. in chemistry from UC Davis with a designated emphasis in biotechnology and clinical translational research, B.Sci in physics, and was a UC Davis Howard Hughes Medical Institute Scholar.